BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27102863)

  • 21. A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer.
    Bahreini F; Soltanian AR; Mehdipour P
    Breast Cancer; 2015 Nov; 22(6):615-25. PubMed ID: 24718809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER2 gene and protein expression status of breast carcinoma can be reliably tested on a single slide.
    Chenard MP; Wissler MP; Weingertner N; Mathelin C; Bellocq JP
    Virchows Arch; 2015 Aug; 467(2):169-75. PubMed ID: 25985875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.
    Yoshida H; Shimada K; Kosuge T; Hiraoka N
    Virchows Arch; 2016 Apr; 468(4):431-9. PubMed ID: 26758058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.
    Hanna WM; Barnes PJ; Chang MC; Gilks CB; Magliocco AM; Rees H; Quenneville L; Robertson SJ; SenGupta SK; Nofech-Mozes S
    J Clin Oncol; 2014 Dec; 32(35):3967-73. PubMed ID: 25385731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.
    Fox SB; Kumarasinghe MP; Armes JE; Bilous M; Cummings MC; Farshid G; Fitzpatrick N; Francis GD; McCloud PI; Raymond W; Morey A
    Am J Surg Pathol; 2012 Apr; 36(4):577-82. PubMed ID: 22314190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
    Ahn S; Hong M; Van Vrancken M; Lyou YJ; Kim ST; Park SH; Kang WK; Park YS; Jung SH; Woo M; Lee J; Kim KM
    Mol Diagn Ther; 2016 Aug; 20(4):375-83. PubMed ID: 27179810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.
    Pyo JS; Kim NY; Kim RH; Kang G
    Brain Tumor Pathol; 2016 Oct; 33(4):248-254. PubMed ID: 27638721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study.
    Liu WL; Wang LW; Chen JM; Yuan JP; Xiang QM; Yang GF; Qu AP; Liu J; Li Y
    Tumour Biol; 2016 Apr; 37(4):5013-24. PubMed ID: 26537585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis.
    Egebjerg K; Garbyal RS; Hasselby JP; Baeksgaard L; Mau-Sørensen M
    Crit Rev Oncol Hematol; 2021 May; 161():103339. PubMed ID: 33865993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
    Wesseling J; Tinterri C; Sapino A; Zanconati F; Lutke-Holzik M; Nguyen B; Deck KB; Querzoli P; Perin T; Giardina C; Seitz G; Guinebretière JM; Barone J; Dekker L; de Snoo F; Stork-Sloots L; Roepman P; Watanabe T; Cusumano P
    Virchows Arch; 2016 Sep; 469(3):297-304. PubMed ID: 27377889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
    Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
    Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: a study of 55 cases.
    Staněk L; Rozkoš T; Laco J; Ryška A; Petruželka L; Důra M; Dundr P
    Mol Med Rep; 2014 Nov; 10(5):2669-74. PubMed ID: 25189406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.
    Tchrakian N; Flanagan L; Harford J; Gannon JM; Quinn CM
    Virchows Arch; 2016 Feb; 468(2):207-11. PubMed ID: 26521061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.
    Moussa M; Badawy A; Helal N; Hegab F; Youssef M; Aboushousha T; Al Faruok L; Elwy D
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2357-2366. PubMed ID: 32856866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER2 immunohistochemistry significantly overestimates HER2 amplification in uterine papillary serous carcinomas.
    Mentrikoski MJ; Stoler MH
    Am J Surg Pathol; 2014 Jun; 38(6):844-51. PubMed ID: 24698965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2 status in gastric cancer: a comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest™).
    Pala EE; Bayol U; Ozguzer A; Akman O
    Pathol Res Pract; 2013 Sep; 209(9):548-54. PubMed ID: 23910175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.
    Yan B; Yau EX; Choo SN; Ong CW; Yong KJ; Pang B; Salto-Tellez M
    J Clin Pathol; 2011 Oct; 64(10):880-3. PubMed ID: 21757431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.
    van Rooijen JM; de Munck L; de Graaf JC; Siesling S; de Vries EG; Boers JE
    Eur J Cancer; 2014 Mar; 50(5):885-91. PubMed ID: 24491395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of HER2 status in breast cancer: the past, the present, and the future.
    Nitta H; Kelly BD; Allred C; Jewell S; Banks P; Dennis E; Grogan TM
    Pathol Int; 2016 Jun; 66(6):313-24. PubMed ID: 27061008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.